Strongbridge Biopharma plc | Business Contracts

First Amendment to Term Loan Agreement, dated July 23, 2021, among Strongbridge Biopharma plc, Strongbridge U.S., Inc. and Avenue Venture Opportunities Fund, L.P (Filed With SEC on July 26, 2021)

Lock-Up Agreement, dated July 23, 2021, between Avenue Venture Opportunities Fund, L.P. and Strongbridge Biopharma plc (Filed With SEC on July 26, 2021)

Employment Agreement, dated as of July 2, 2020, by and between Strongbridge U.S. Inc. and John Johnson (Filed With SEC on August 4, 2020)

Form of Indemnification Agreement (Filed With SEC on February 28, 2020)

Underwriting Agreement, dated as of September 16, 2020, by and between Strongbridge Biopharma plc and Jefferies LLC and Stifel, Nicolaus and Company, Incorporated, as... (Filed With SEC on September 18, 2020)

Amendment to Executive Chairman Agreement (Filed With SEC on April 10, 2020)

Description of Ordinary Shares (Filed With SEC on February 28, 2020)

Form of Restricted Stock Unit Award Agreement under the Strongbridge Biopharma Non-Employee Director Equity Compensation Plan (Filed With SEC on February 28, 2020)

Executive Chairman Agreement, dated as of November 1, 2019, by and between Strongbridge Biopharma plc and John Johnson (Filed With SEC on February 28, 2020)

Amendment to Option Award Agreements, dated as of November 26, 2019, by and between Strongbridge Biopharma plc and Matthew Pauls (Filed With SEC on February 28, 2020)

Consulting Agreement by and between Strongbridge U.S. Inc. and A. Brian Davis, dated as of September 3, 2019 (Filed With SEC on November 7, 2019)

Strongbridge Biopharma plc 2015 Equity Compensation Plan (Filed With SEC on February 27, 2019)

Strongbridge Biopharma plc Non-Employee Director Equity Compensation Plan (Filed With SEC on February 27, 2019)

Strongbridge Biopharma plc 2017 Inducement Plan (Filed With SEC on February 27, 2019)

Strongbridge Biopharma plc (14)